Sartorius AG (SOAGY)
58.53
-0.31
(-0.53%)
USD |
OTCM |
Aug 28, 16:00
Sartorius Free Cash Flow : 321.06M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 321.06M |
| March 31, 2026 | 302.46M |
| December 31, 2025 | 242.56M |
| September 30, 2025 | 319.67M |
| June 30, 2025 | 417.33M |
| March 31, 2025 | 542.68M |
| December 31, 2024 | 387.15M |
| September 30, 2024 | 302.27M |
| June 30, 2024 | 266.28M |
| March 31, 2024 | 37.41M |
| December 31, 2023 | 199.82M |
| September 30, 2023 | 121.15M |
| June 30, 2023 | 146.23M |
| March 31, 2023 | 143.88M |
| December 31, 2022 | 183.52M |
| September 30, 2022 | 139.59M |
| June 30, 2022 | 233.22M |
| March 31, 2022 | 440.90M |
| December 31, 2021 | 514.19M |
| September 30, 2021 | 480.13M |
| June 30, 2021 | 503.60M |
| March 31, 2021 | 397.79M |
| December 31, 2020 | 290.06M |
| September 30, 2020 | 321.61M |
| June 30, 2020 | 226.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 155.72M |
| December 31, 2019 | 140.76M |
| September 30, 2019 | 71.31M |
| June 30, 2019 | 50.49M |
| March 31, 2019 | 47.62M |
| December 31, 2018 | -10.35M |
| September 30, 2018 | 15.68M |
| June 30, 2018 | 12.75M |
| March 31, 2018 | 2.712M |
| December 31, 2017 | -8.389M |
| September 30, 2017 | -8.783M |
| June 30, 2017 | 6.312M |
| March 31, 2017 | 11.02M |
| December 31, 2016 | 13.29M |
| September 30, 2016 | -19.87M |
| June 30, 2016 | -40.67M |
| March 31, 2016 | 0.4301M |
| December 31, 2015 | 2.911M |
| September 30, 2015 | 64.70M |
| June 30, 2015 | 62.40M |
| March 31, 2015 | 30.71M |
| December 31, 2014 | 40.02M |
| September 30, 2014 | 20.40M |
| June 30, 2014 | 43.98M |
| March 31, 2014 | 45.23M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Mesa Laboratories, Inc. | 52.87M |
| Austar Lifesciences Ltd. | 26.83M |
| SCHOTT Pharma AG & Co. KGaA | 65.97M |
| Agilent Technologies, Inc. | 1.267B |
| Bio-Rad Laboratories, Inc. | 353.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 182.17M |
| Cash from Investing (Quarterly) | -175.22M |
| Cash from Financing (Quarterly) | -340.21M |
| Free Cash Flow Per Share (Quarterly) | 0.2453 |
| Free Cash Flow to Equity (Quarterly) | 407.44M |
| Free Cash Flow to Firm (Quarterly) | 128.67M |
| Free Cash Flow Yield | 1.59% |